JP2025507915A5 - - Google Patents

Info

Publication number
JP2025507915A5
JP2025507915A5 JP2024552219A JP2024552219A JP2025507915A5 JP 2025507915 A5 JP2025507915 A5 JP 2025507915A5 JP 2024552219 A JP2024552219 A JP 2024552219A JP 2024552219 A JP2024552219 A JP 2024552219A JP 2025507915 A5 JP2025507915 A5 JP 2025507915A5
Authority
JP
Japan
Prior art keywords
heterocycloalkyl
cycloalkyl
alkyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024552219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/078973 external-priority patent/WO2023165509A1/en
Publication of JP2025507915A publication Critical patent/JP2025507915A/ja
Publication of JP2025507915A5 publication Critical patent/JP2025507915A5/ja
Pending legal-status Critical Current

Links

JP2024552219A 2022-03-01 2023-03-01 ジアシルグリセロールキナーゼ(DGK)α阻害剤及びその使用 Pending JP2025507915A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN2022078655 2022-03-01
CNPCT/CN2022/078655 2022-03-01
CNPCT/CN2022/091215 2022-05-06
CN2022091215 2022-05-06
CN2022128282 2022-10-28
CNPCT/CN2022/128282 2022-10-28
CN2023071962 2023-01-12
CNPCT/CN2023/071962 2023-01-12
PCT/CN2023/078973 WO2023165509A1 (en) 2022-03-01 2023-03-01 Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025507915A JP2025507915A (ja) 2025-03-21
JP2025507915A5 true JP2025507915A5 (cg-RX-API-DMAC7.html) 2026-03-09

Family

ID=87883015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024552219A Pending JP2025507915A (ja) 2022-03-01 2023-03-01 ジアシルグリセロールキナーゼ(DGK)α阻害剤及びその使用

Country Status (7)

Country Link
US (1) US20250214990A1 (cg-RX-API-DMAC7.html)
EP (1) EP4486745A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025507915A (cg-RX-API-DMAC7.html)
CN (1) CN118829642A (cg-RX-API-DMAC7.html)
AR (1) AR128668A1 (cg-RX-API-DMAC7.html)
TW (1) TW202342478A (cg-RX-API-DMAC7.html)
WO (1) WO2023165509A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL315015A (en) 2022-03-01 2024-10-01 Insilico Medicine Ip Ltd Diacylglycerol kinase (DGK) alpha inhibitors and their uses
TW202436351A (zh) 2023-02-06 2024-09-16 德商拜耳廠股份有限公司 Ccr8抗體及dgk抑制劑之組合
CN122094689A (zh) * 2023-09-04 2026-05-26 英矽智能科技知识产权有限公司 二酰甘油激酶(DGK)α抑制剂与其他疗法的组合治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011075747A1 (en) * 2009-12-18 2011-06-23 Glaxosmithkline Llc Therapeutic compounds
CN112654621B (zh) * 2018-06-27 2024-05-14 百时美施贵宝公司 可作为t细胞活化剂的经取代萘啶酮化合物
WO2021105115A1 (en) * 2019-11-28 2021-06-03 Bayer Aktiengesellschaft Substituted aminoquinolones as dgkalpha inhibitors for immune activation
IL294148A (en) * 2019-12-23 2022-08-01 Bristol Myers Squibb Co Substituted quinazolinyl compounds are useful as t-cell activators
CN115362003B (zh) * 2019-12-24 2024-03-22 卡尔那生物科学株式会社 二酰基甘油激酶调节化合物
MX2023014762A (es) * 2021-06-23 2024-01-15 Gilead Sciences Inc Compuestos moduladores de diacilglicerol quinasa.

Similar Documents

Publication Publication Date Title
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2024541910A5 (cg-RX-API-DMAC7.html)
JP2020530487A5 (cg-RX-API-DMAC7.html)
JP2020169171A5 (cg-RX-API-DMAC7.html)
JP2025508971A5 (cg-RX-API-DMAC7.html)
JP2021527638A5 (cg-RX-API-DMAC7.html)
JP2005508349A5 (cg-RX-API-DMAC7.html)
JP2022522694A5 (cg-RX-API-DMAC7.html)
JP2016121196A5 (cg-RX-API-DMAC7.html)
JP2019034943A5 (cg-RX-API-DMAC7.html)
JP2025502943A5 (cg-RX-API-DMAC7.html)
JP2025513882A5 (cg-RX-API-DMAC7.html)
JP2021522280A5 (cg-RX-API-DMAC7.html)
JP2023520925A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2012526728A5 (cg-RX-API-DMAC7.html)
JP2011529918A5 (cg-RX-API-DMAC7.html)
JP2009507909A5 (cg-RX-API-DMAC7.html)
JP2012519691A5 (cg-RX-API-DMAC7.html)
JP2024542969A5 (cg-RX-API-DMAC7.html)
CA2537114A1 (en) Tricyclic nucleosides or nucleotides as therapeutic agents
JP2009526868A5 (cg-RX-API-DMAC7.html)
JP2006505543A5 (cg-RX-API-DMAC7.html)
JP2025507292A5 (cg-RX-API-DMAC7.html)
JP2022511477A5 (cg-RX-API-DMAC7.html)